Prairie Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Hold
0
96
2025
Q4
Sell
-1,660
Closed -$378K 95
2025
Q3
$384K Hold
1,660
0.16% 97
2025
Q2
$308K Hold
1,660
0.13% 114
2025
Q1
$348K Sell
1,660
-587
-26% -$114K 0.17% 99
2024
Q4
$399K Sell
2,247
-60
-3% -$11K 0.19% 92
2024
Q3
$456K Buy
2,307
+14
+0.6% +$2.61K 0.23% 87
2024
Q2
$393K Sell
2,293
-951
-29% -$158K 0.2% 87
2024
Q1
$591K Buy
+3,244
New +$559K 0.28% 75

Other funds holding ABBV

Prairie Wealth Advisors's ABBV Position: Q1 2026 in Review

Prairie Wealth Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 0 shares worth $372K. The position accounts for 0.16% of the portfolio, ranked #96.

Prairie Wealth Advisors first reported a position in ABBV in Q1 2024 and has held it in 7 quarters since. The position peaked at $591K in Q1 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Prairie Wealth Advisors held 0 shares of AbbVie worth $372K as of Q1 2026.
  • Prairie Wealth Advisors left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.16% of Prairie Wealth Advisors's portfolio in Q1 2026, its #96 holding.
  • Prairie Wealth Advisors first reported a position in AbbVie in Q1 2024 and has held it in 7 quarters since.
  • Prairie Wealth Advisors's AbbVie position peaked at $591K in Q1 2024.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Prairie Wealth Advisors's 13F filing for Q1 2026, filed 5 May 2026.